Department of Pharmaceutical Health Chemistry, Graduate School of Pharmaceutical Sciences, Tokushima University, 1-78-1 Shomachi, Tokushima 770-8505, Japan.
Graduate School of Biomedical Sciences, Tokushima University, 1-78-1 Shomachi, Tokushima 770-8505, Japan.
Biochim Biophys Acta Gen Subj. 2023 Dec;1867(12):130485. doi: 10.1016/j.bbagen.2023.130485. Epub 2023 Oct 12.
Vitamin E succinate (VES) is an esterified form of natural α-tocopherol, has turned out to be novel anticancer agent. However, its anticancer mechanisms have not been illustrated. Previously, we reported VES mediated Ca release from the endoplasmic reticulum (ER) causes mitochondrial Ca overload, leading to mitochondrial depolarization and apoptosis. Here, we elucidated the mechanism of VES-induced Ca transfer from ER to mitochondria by investigating the role of VES in ER-mitochondria contact formation. Transmission electron microscopic observation confirms VES mediated ER-mitochondria contact while fluorescence microscopic analysis revealed that VES increased mitochondria-associated ER membrane (MAM) formation. Pre-treatment with the inositol 1,4,5-triphosphate receptor (IPR) antagonist 2-aminoethyl diphenylborinate (2-APB) decreased VES-induced MAM formation, suggesting the involvement of VES-induced Ca efflux from ER in MAM formation. The ER IPR receptor is known to interact with voltage-dependent anion channels (VDAC) via the chaperone glucose-regulated protein 75 kDa (GRP75) to bring ER and mitochondria nearby. Although we revealed that VES treatment does not affect GRP75 protein level, it increases GRP75 localization in the MAM. In addition, the inhibition of Ca release from ER by 2-APB decreases GRP75 localization in the MAM, suggesting the possibility of Ca-induced conformational change of GRP75 that promotes formation of the IPR-GRP75-VDAC complex and thereby encourages MAM formation. This study identifies the mechanism of VES-induced enhanced Ca transfer from ER to mitochondria, which causes mitochondrial Ca overload leading to apoptosis.
维生素 E 琥珀酸酯 (VES) 是天然 α-生育酚的酯化形式,已被证明是一种新型的抗癌药物。然而,其抗癌机制尚未阐明。此前,我们报道过 VES 介导的内质网 (ER) 内钙释放导致线粒体钙超载,从而引起线粒体去极化和细胞凋亡。在这里,我们通过研究 VES 在 ER-线粒体接触形成中的作用,阐明了 VES 诱导的 ER 向线粒体钙转移的机制。透射电子显微镜观察证实 VES 介导的 ER-线粒体接触,而荧光显微镜分析显示 VES 增加了线粒体相关内质网膜 (MAM) 的形成。内质网肌醇 1,4,5-三磷酸受体 (IPR) 拮抗剂 2-氨基乙基二苯基硼酸盐 (2-APB) 的预处理降低了 VES 诱导的 MAM 形成,表明 VES 诱导的 ER 钙内流参与了 MAM 的形成。已知内质网 IPR 受体通过伴侣葡萄糖调节蛋白 75 kDa (GRP75) 与电压依赖性阴离子通道 (VDAC) 相互作用,使内质网和线粒体靠近。尽管我们发现 VES 处理不会影响 GRP75 蛋白水平,但它会增加 GRP75 在 MAM 中的定位。此外,用 2-APB 抑制 ER 钙释放会降低 MAM 中 GRP75 的定位,这表明钙可能诱导 GRP75 构象发生变化,促进 IPR-GRP75-VDAC 复合物的形成,从而促进 MAM 的形成。本研究确定了 VES 诱导的增强 ER 向线粒体钙转移的机制,这导致线粒体钙超载,从而引发细胞凋亡。